Publications

EANM Journals

Find out more about our new journals: The EANM Journal and EANM Innovation.

EANM / Publications / EANM Journals

Discover EANM's two open-access journals!

In February 2025, EANM took an exciting step forward, establishing its two own open-access journals to drive innovation, facilitate knowledge exchange, and strengthen collaboration with allied sciences.

Both journals are published as online-only by the world-leading publisher Elsevier.

Overview


1) The EANM Journal: Our flagship journal

The EANM Journal aims to establish itself as the leading global publication for nuclear medicine and allied sciences. It focuses on high-impact studies exploring the use of radiopharmaceuticals and other imaging probes in both diagnostic and therapeutic applications.  

Editor-in-Chief: Arturo Chiti

Website Submission platform


2) EANM Innovation: Our broad-scope journal

Designed to be the new reference platform for the nuclear medicine community, EANM Innovation highlights significant contributions from professionals across the field, fostering knowledge exchange and collaboration within the scientific community.

Editor-in-Chief: Riemer Slart

Website Submission platform

 

Why publish with us?


Both journals are designed to offer a smooth, author-friendly publishing experience, featuring:

•  Fully open access – Maximising visibility and accessibility of your research
•  Flexible submissions – No strict formatting required for initial submissions
•  Efficient peer review – A streamlined process for quick and effective decision-making
•  Author-centered approach – A dedicated editorial team providing a seamless publishing experience

Let’s keep in touch!


Got questions about preparing your manuscript, the editorial process, or peer review? Interested in making a pre-submission inquiry? Please contact Esther Pilla (EANM Editorial Manager) at editorial.office@eanm.org. We’re here to help every step of the way!

In addition, stay informed by following us on our social media channels and subscribing to our newsletters.